questionsmedicales.fr
Composés hétérocycliques
Composés hétéromonocycliques
Pyridines
Composés de pyridinium
Composés de pyridinium : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Intoxication
Tests sanguins
Analyse chromatographique
Spectrométrie
Nausées
Troubles neurologiques
Tests urinaires
Métabolites
Historique médical
Symptômes
Symptômes
5
Douleurs abdominales
Troubles respiratoires
Éruptions cutanées
Irritations
Évolution des symptômes
Intervention rapide
Prévention
5
Équipements de protection
Exposition
Formations
Sécurité chimique
Fuites
Protocoles de sécurité
Traitements
5
Décontamination
Antidotes
Soins de soutien
Hydratation
Surveillance
Complications
Complications
5
Lésions organiques
Troubles respiratoires
Effets à long terme
Troubles cognitifs
Prise en charge médicale
Suivi régulier
Intervention rapide
Traitement approprié
Difficultés respiratoires
Confusion mentale
Facteurs de risque
5
Travailleurs en chimie
Industrie
Jeunes enfants
Personnes âgées
Antécédents médicaux
Maladies respiratoires
Conditions environnementales
Chaleur
Interactions médicamenteuses
Toxicité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composés de pyridinium : Questions médicales les plus fréquentes",
"headline": "Composés de pyridinium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composés de pyridinium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-05",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composés de pyridinium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pyridines",
"url": "https://questionsmedicales.fr/mesh/D011725",
"about": {
"@type": "MedicalCondition",
"name": "Pyridines",
"code": {
"@type": "MedicalCode",
"code": "D011725",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cétylpyridinium",
"alternateName": "Cetylpyridinium",
"url": "https://questionsmedicales.fr/mesh/D002594",
"about": {
"@type": "MedicalCondition",
"name": "Cétylpyridinium",
"code": {
"@type": "MedicalCode",
"code": "D002594",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.232"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diquat",
"alternateName": "Diquat",
"url": "https://questionsmedicales.fr/mesh/D004178",
"about": {
"@type": "MedicalCondition",
"name": "Diquat",
"code": {
"@type": "MedicalCode",
"code": "D004178",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.352"
}
}
},
{
"@type": "MedicalWebPage",
"name": "1-Méthyl-4-phényl-pyridinium",
"alternateName": "1-Methyl-4-phenylpyridinium",
"url": "https://questionsmedicales.fr/mesh/D015655",
"about": {
"@type": "MedicalCondition",
"name": "1-Méthyl-4-phényl-pyridinium",
"code": {
"@type": "MedicalCode",
"code": "D015655",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chlorure d'obidoxime",
"alternateName": "Obidoxime Chloride",
"url": "https://questionsmedicales.fr/mesh/D009768",
"about": {
"@type": "MedicalCondition",
"name": "Chlorure d'obidoxime",
"code": {
"@type": "MedicalCode",
"code": "D009768",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Paraquat",
"alternateName": "Paraquat",
"url": "https://questionsmedicales.fr/mesh/D010269",
"about": {
"@type": "MedicalCondition",
"name": "Paraquat",
"code": {
"@type": "MedicalCode",
"code": "D010269",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.621"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bromure de pyridostigmine",
"alternateName": "Pyridostigmine Bromide",
"url": "https://questionsmedicales.fr/mesh/D011729",
"about": {
"@type": "MedicalCondition",
"name": "Bromure de pyridostigmine",
"code": {
"@type": "MedicalCode",
"code": "D011729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.740"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trimédoxime",
"alternateName": "Trimedoxime",
"url": "https://questionsmedicales.fr/mesh/D014289",
"about": {
"@type": "MedicalCondition",
"name": "Trimédoxime",
"code": {
"@type": "MedicalCode",
"code": "D014289",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.900"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Viologènes",
"alternateName": "Viologens",
"url": "https://questionsmedicales.fr/mesh/D014755",
"about": {
"@type": "MedicalCondition",
"name": "Viologènes",
"code": {
"@type": "MedicalCode",
"code": "D014755",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.925"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Benzyl viologène",
"alternateName": "Benzyl Viologen",
"url": "https://questionsmedicales.fr/mesh/D001594",
"about": {
"@type": "MedicalCondition",
"name": "Benzyl viologène",
"code": {
"@type": "MedicalCode",
"code": "D001594",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.925.100"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Composés de pyridinium",
"alternateName": "Pyridinium Compounds",
"code": {
"@type": "MedicalCode",
"code": "D011726",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sungwoo Hong",
"url": "https://questionsmedicales.fr/author/Sungwoo%20Hong",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Korea hongorg@kaist.ac.kr."
}
},
{
"@type": "Person",
"name": "Werner Fudickar",
"url": "https://questionsmedicales.fr/author/Werner%20Fudickar",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Potsdam, Potsdam, Germany."
}
},
{
"@type": "Person",
"name": "Torsten Linker",
"url": "https://questionsmedicales.fr/author/Torsten%20Linker",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Potsdam, Potsdam, Germany."
}
},
{
"@type": "Person",
"name": "Lihua Luo",
"url": "https://questionsmedicales.fr/author/Lihua%20Luo",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China."
}
},
{
"@type": "Person",
"name": "Rui Sun",
"url": "https://questionsmedicales.fr/author/Rui%20Sun",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cognitive profile in functional disorders.",
"datePublished": "2023-11-30",
"url": "https://questionsmedicales.fr/article/37889124",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13546805.2023.2275336"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Uric acid, cognitive disorders, neurodegeneration].",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38829804",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.26442/00403660.2024.05.202698"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive subgroups and their longitudinal trajectories in bipolar disorder.",
"datePublished": "2022-06-25",
"url": "https://questionsmedicales.fr/article/35690884",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/acps.13460"
}
},
{
"@type": "ScholarlyArticle",
"name": "An evolutionary account of impairment of self in cognitive disorders.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36180662",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10339-022-01110-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive impairment in bipolar disorder in comparison to mild cognitive impairment and dementia: a systematic review.",
"datePublished": "2023-02-20",
"url": "https://questionsmedicales.fr/article/34374270",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.47626/2237-6089-2021-0300"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pyridines",
"item": "https://questionsmedicales.fr/mesh/D011725"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composés de pyridinium",
"item": "https://questionsmedicales.fr/mesh/D011726"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composés de pyridinium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composés de pyridinium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composés de pyridinium",
"description": "Comment diagnostiquer une intoxication aux composés de pyridinium ?\nQuels tests sont utilisés pour détecter les composés de pyridinium ?\nQuels symptômes indiquent une exposition aux pyridiniums ?\nLes tests urinaires peuvent-ils détecter les pyridiniums ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Cognition+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composés de pyridinium",
"description": "Quels sont les symptômes courants d'une exposition aux pyridiniums ?\nLes composés de pyridinium provoquent-ils des effets neurologiques ?\nY a-t-il des symptômes cutanés associés aux pyridiniums ?\nLes symptômes varient-ils selon le type de pyridinium ?\nComment les symptômes évoluent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Cognition+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composés de pyridinium",
"description": "Quelles mesures préventives peuvent réduire l'exposition aux pyridiniums ?\nLes formations sont-elles nécessaires pour manipuler des pyridiniums ?\nComment stocker les composés de pyridinium en toute sécurité ?\nLes fuites de pyridiniums peuvent-elles être évitées ?\nQuelles sont les recommandations pour les laboratoires ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Cognition+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composés de pyridinium",
"description": "Quel est le traitement principal en cas d'intoxication aux pyridiniums ?\nLes soins de soutien sont-ils nécessaires pour les patients exposés ?\nQuels antidotes sont utilisés contre les pyridiniums ?\nLa dialyse est-elle efficace pour éliminer les pyridiniums ?\nComment prévenir les complications lors du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Cognition+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composés de pyridinium",
"description": "Quelles complications peuvent survenir après une exposition aux pyridiniums ?\nLes effets à long terme des pyridiniums sont-ils connus ?\nComment les complications sont-elles gérées ?\nLes complications peuvent-elles être évitées ?\nQuels sont les signes d'alerte pour des complications graves ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Cognition+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composés de pyridinium",
"description": "Quels sont les principaux facteurs de risque d'exposition aux pyridiniums ?\nL'âge influence-t-il la sensibilité aux pyridiniums ?\nLes antécédents médicaux augmentent-ils le risque d'intoxication ?\nLes conditions environnementales jouent-elles un rôle ?\nLes interactions médicamenteuses sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Cognition+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux composés de pyridinium ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les composés de pyridinium ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses chromatographiques et spectrométriques sont couramment utilisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux pyridiniums ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les tests urinaires peuvent-ils détecter les pyridiniums ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains tests urinaires peuvent révéler la présence de métabolites pyridiniques."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux pyridiniums."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition aux pyridiniums ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des vertiges et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Les composés de pyridinium provoquent-ils des effets neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer des maux de tête, des convulsions et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés aux pyridiniums ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées et des irritations peuvent survenir après contact avec ces composés."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de pyridinium ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la structure chimique et de la dose."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver sans traitement approprié, nécessitant une intervention rapide."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives peuvent réduire l'exposition aux pyridiniums ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle lors de la manipulation de ces composés."
}
},
{
"@type": "Question",
"name": "Les formations sont-elles nécessaires pour manipuler des pyridiniums ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des formations sur la sécurité chimique sont essentielles pour les travailleurs exposés."
}
},
{
"@type": "Question",
"name": "Comment stocker les composés de pyridinium en toute sécurité ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les stocker dans des contenants hermétiques et étiquetés, à l'écart des sources de chaleur."
}
},
{
"@type": "Question",
"name": "Les fuites de pyridiniums peuvent-elles être évitées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en vérifiant régulièrement les équipements et en respectant les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les laboratoires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les laboratoires doivent suivre des protocoles stricts de manipulation et de stockage des pyridiniums."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication aux pyridiniums ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la décontamination et l'administration d'antidotes spécifiques."
}
},
{
"@type": "Question",
"name": "Les soins de soutien sont-ils nécessaires pour les patients exposés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins de soutien, comme l'hydratation et la surveillance, sont souvent requis."
}
},
{
"@type": "Question",
"name": "Quels antidotes sont utilisés contre les pyridiniums ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antidotes comme l'atropine peuvent être administrés pour contrer les effets toxiques."
}
},
{
"@type": "Question",
"name": "La dialyse est-elle efficace pour éliminer les pyridiniums ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dialyse peut être envisagée dans les cas graves d'intoxication pour éliminer les toxines."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications lors du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance étroite et un traitement rapide des symptômes sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition aux pyridiniums ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des lésions organiques, des troubles neurologiques et respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les effets à long terme des pyridiniums sont-ils connus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes respiratoires chroniques."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent une prise en charge médicale spécialisée et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une intervention rapide et un traitement approprié peuvent réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'alerte pour des complications graves ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des difficultés respiratoires, des convulsions ou une confusion mentale doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition aux pyridiniums ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en chimie, agriculture et industrie sont les plus exposés aux pyridiniums."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité aux pyridiniums ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus sensibles aux effets toxiques."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque d'intoxication ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou neurologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales jouent-elles un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme la chaleur ou l'humidité peuvent exacerber les effets des pyridiniums."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions médicamenteuses peuvent augmenter la toxicité des pyridiniums."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 31/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Korea hongorg@kaist.ac.kr.
Center for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science (IBS) Daejeon 34141 Korea.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Potsdam, Potsdam, Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Potsdam, Potsdam, Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Xi'an Medical University, Xi'an, Shaanxi 710021, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Korea hongorg@kaist.ac.kr.
Center for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science (IBS) Daejeon 34141 Korea.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Georg-August Universität Göttingen , Tammannstraße 2 , 37077 Göttingen , Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Georg-August Universität Göttingen , Tammannstraße 2 , 37077 Göttingen , Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, Illinois, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
Patients with functional disorders (FD) often experience cognitive problems such as forgetfulness and distractibility alongside physical symptoms that cannot be attributed to a known somatic disease....
Test scores of cognitive tests and psychiatric rating scales of 100 outpatients diagnosed with a functional disorder were compared to a control group (n = 300) of patients with other diagnoses and to ...
Out of the 100 patients with functional disorders, 59 reported significant subjective cognitive symptoms. A moderate difference (d = 0.5-0.7) was found between the FD group mean and the population mea...
The findings of the study suggest that a decline in processing speed is a central feature in the cognitive profile of patients with functional disorders....
This article examines the role of uric acid (UA) in cognitive changes and neurodegeneration, focusing on its functions as an antioxidant and prooxidant. Research suggests that changes in serum UA leve...
Cognitive functioning in bipolar disorder is heterogeneous with evidence for multiple subgroups. However, cognitive subgroup change patterns over time remains unknown. While prior work suggests minima...
Participants diagnosed with bipolar disorder (I, II, NOS; n = 568) and unaffected controls (n = 234) completed baseline, one- and five-year neuropsychological assessments. Data reduction techniques we...
Results were consistent with bipolar disorder participants forming three subgroups with high (n = 209), mid (n = 259), and low (n = 100) cognition. These groups were associated with unique clinical ch...
These results demonstrate that cognition-based subgroups of bipolar disorder participants have minimal differences in their longitudinal course in relation to each other and with unaffected controls....
Recent research has proposed that certain aspects of psychosis, as experienced in, e.g., schizophrenia (SCZ), but also aspects of other cognitive conditions, such as autism spectrum disorders (ASD) an...
To conduct a systematic review to describe cognitive abilities in bipolar disorder (BD) in comparison to cognitive abilities in mild cognitive impairment (MCI) and dementia....
A literature search was performed with no year or language restrictions. The search yielded 1,461 articles, with 1,261 remaining after removal of duplicates, five of which were suitable for the system...
Analyses from our systematic review showed that euthymic individuals with BD present impairments in cognitive domains such as attention and executive functioning, motor skills, conceptual thinking, an...
Findings from our systematic review suggest that cognitive impairments in euthymic BD fall into a range between the impairments seen in MCI and those seen in dementia. More studies are needed to analy...
Cognitive deficits are prevalent in bipolar disorder even during the euthymic phase, having a negative impact on global functioning and quality of life. As such, more and more mental health profession...
The aim of this study was to assess the knowledge, attitudes and the rules of proceeding concerning primary health care (PHC) doctors in the field of screening diagnostics for cognitive disorders in e...
The study included 175 PHC doctors. A validated anonymous questionnaire was used. The survey was conducted using the PAPI (Paper and Pencil Interviews) and CAWI (Computer Assisted Web Interviews) meth...
The vast majority of the respondents (n=159; 91.4%) saw the advisability of screening for cognitive disorders in the age group >65 years of age, but only 53 subjects (30.29%) believed that these tests...
Polish GPs are aware of the necessity of screening for cognitive disorders in seniors. Currently, there are no mechanisms within primary health care system that would enable proper early screening for...
Functional cognitive disorders (FCDs) are a common cause of subjective and mild cognitive impairment. Isolated FCDs commonly present to the cognitive clinic, but examination of the nature of the sympt...
Cognitive impairment is a core feature of mood disorders and has been identified as an important treatment target. A better understanding of the factors contributing to cognitive impairment in mood di...
Studies in adult samples examining the relationship between objective cognitive function and reported childhood trauma in major depressive disorder and/or bipolar disorder (in-episode or euthymia) wer...
Seventeen studies met the criteria for inclusion (mood disorders N = 1723, healthy controls N = 797). Evidence for childhood trauma being related to poorer cognitive functioning was consistent across ...
Findings from this review suggest childhood trauma is associated with poorer cognitive functioning in people with mood disorders. Targeted interventions to improve cognition may be warranted for this ...
Extensive literature has explored the beneficial effects of music in age-related cognitive disorders (ACD), but limited knowledge exists regarding its impact on gene expression. We analyzed transcript...